Cagan Gurer

Cagan Gurer

Company: TScan Therapeutics

Job title: VP, Discovery


Expanding Patient Coverage for TCR-T Therapies by Broadening HLA Type Targeting 9:30 am

• Application of TargetScan discovery platform to diverse HLA types for novel target epitope identification • Using ReceptorScan to identify lead TCRs for novel HLA epitopes • Leveraging proprietary human proteome libraries across diverse HLAs to assess potential off-target safety risks for TCRsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.